Chris van Ingen, the head of Agilent Technologies’ Life Sciences and Chemical Analysis business unit, told analysts Monday that there is a “resurgence” in DNA analysis based on microarray-based applications for comparative genomic hybridization and location analysis.

Microarray analysis of RNA is the larger part of the microarray market, where Agilent is considered the No. 2 player after dominant Affymetrix. It’s a market that is regarded as nearing maturity, with sales growth leveling off as whole-genome microarrays move toward near-commodity status.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers in the UK and Australia uncover genetic links between BMI and depression, the Guardian reports.

The Verge details the account of an academic who alleges her university retaliated against her after she complained of sexual harassment by her supervisor.

The New York Times writes that natural history museums are helping round out genetic studies with older specimens.

In PNAS this week: artemisinin resistance mutations in malaria parasites, ant-plant interactions over time, and more.